ClinicalTrials.Veeva

Menu

Local Recurrence Prediction of by Texture Analysis Derived From Positron Emission Tomography (PET / CT) Imaging of Non-small Cell Lung Cancer (NSCLC) Treated With Stereotactic Radiotherapy (SBRT) (Retros MUMOFRAT) (MUMOFRAT retro)

R

Regional University Hospital Center (CHRU)

Status

Completed

Conditions

Identify FDG PET/CT Parameters Predictive of Local Control

Study type

Observational

Funder types

Other

Identifiers

NCT06555861
29BRC18.0283 - Retros MUMOFRAT

Details and patient eligibility

About

The aim of this retrospective multicentric study was to develop and evaluate a prognostic FDG PET/CT radiomics signature in early-stage non-small cell lung cancer (NSCLC) patients treated with stereotactic radiotherapy (SBRT).

Enrollment

87 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • NSCLC stage I-II treated by SBRT
  • PET/CT imaging performed within 60 days of SBRT

Exclusion criteria

  • Lack of follow-up
  • Refusal of consent

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems